Literature DB >> 12682352

A major outbreak of severe acute respiratory syndrome in Hong Kong.

Nelson Lee1, David Hui, Alan Wu, Paul Chan, Peter Cameron, Gavin M Joynt, Anil Ahuja, Man Yee Yung, C B Leung, K F To, S F Lui, C C Szeto, Sydney Chung, Joseph J Y Sung.   

Abstract

BACKGROUND: There has been an outbreak of the severe acute respiratory syndrome (SARS) worldwide. We report the clinical, laboratory, and radiologic features of 138 cases of suspected SARS during a hospital outbreak in Hong Kong.
METHODS: From March 11 to 25, 2003, all patients with suspected SARS after exposure to an index patient or ward were admitted to the isolation wards of the Prince of Wales Hospital. Their demographic, clinical, laboratory, and radiologic characteristics were analyzed. Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed.
RESULTS: There were 66 male patients and 72 female patients in this cohort, 69 of whom were health care workers. The most common symptoms included fever (in 100 percent of the patients); chills, rigors, or both (73.2 percent); and myalgia (60.9 percent). Cough and headache were also reported in more than 50 percent of the patients. Other common findings were lymphopenia (in 69.6 percent), thrombocytopenia (44.8 percent), and elevated lactate dehydrogenase and creatine kinase levels (71.0 percent and 32.1 percent, respectively). Peripheral air-space consolidation was commonly observed on thoracic computed tomographic scanning. A total of 32 patients (23.2 percent) were admitted to the intensive care unit; 5 patients died, all of whom had coexisting conditions. In a multivariate analysis, the independent predictors of an adverse outcome were advanced age (odds ratio per decade of life, 1.80; 95 percent confidence interval, 1.16 to 2.81; P=0.009), a high peak lactate dehydrogenase level (odds ratio per 100 U per liter, 2.09; 95 percent confidence interval, 1.28 to 3.42; P=0.003), and an absolute neutrophil count that exceeded the upper limit of the normal range on presentation (odds ratio, 1.60; 95 percent confidence interval, 1.03 to 2.50; P=0.04).
CONCLUSIONS: SARS is a serious respiratory illness that led to significant morbidity and mortality in our cohort. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682352     DOI: 10.1056/NEJMoa030685

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  1038 in total

1.  Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection.

Authors:  P Li; J-F Zhang; X-D Xia; D-J Su; B-L Liu; D-L Zhao; Y Liu; D-H Zhao
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  SARS update.

Authors:  James Maskalyk; John Hoey
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

Review 3.  SARS coronavirus: a new challenge for prevention and therapy.

Authors:  Kathryn V Holmes
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 4.  Antiviral treatment of SARS: can we draw any conclusions?

Authors:  Getu Zhaori
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

5.  Why SARS will not return: a polemic.

Authors:  Donald E Low
Journal:  CMAJ       Date:  2004-01-06       Impact factor: 8.262

6.  Severe acute respiratory syndrome: private hospital in Singapore took effective control measures.

Authors:  S C Yeoh; E Lee; B W Lee; D L Goh
Journal:  BMJ       Date:  2003-06-21

Review 7.  Severe acute respiratory syndrome and its lesions in digestive system.

Authors:  Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

8.  Lessons from taiwan.

Authors:  Li-chien Chien; Wen-Bin Yeh; Hong-Tai Chang
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

Review 9.  Severe acute respiratory syndrome (SARS): epidemiology and clinical features.

Authors:  D S C Hui; M C H Chan; A K Wu; P C Ng
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

10.  Small molecules targeting severe acute respiratory syndrome human coronavirus.

Authors:  Chung-Yi Wu; Jia-Tsrong Jan; Shiou-Hwa Ma; Chih-Jung Kuo; Hsueh-Fen Juan; Yih-Shyun E Cheng; Hsien-Hua Hsu; Hsuan-Cheng Huang; Douglass Wu; Ashraf Brik; Fu-Sen Liang; Rai-Shung Liu; Jim-Min Fang; Shui-Tein Chen; Po-Huang Liang; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.